MedPath

CIPLA USA INC.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Plazomicin Study in ESRD Patients Receiving IHD

Phase 1
Completed
Conditions
End Stage Renal Disease
Interventions
First Posted Date
2021-01-07
Last Posted Date
2022-03-09
Lead Sponsor
Cipla USA Inc.
Target Recruit Count
6
Registration Number
NCT04699656
Locations
🇺🇸

Orlando Clinical Research Center, Orlando, Florida, United States

© Copyright 2025. All Rights Reserved by MedPath